Cargando…
Association of TNFRSF1B Promoter Polymorphisms with Human Disease: Further Studies Examining T-Regulatory Cells Are Required
The TNFR2 receptor is expressed by highly active regulatory T cells, and thus constitutes an important therapeutic target for the treatment of autoimmune disease and cancer. Disease susceptibility as well as the potential response to therapies directed at TNFR2 could be significantly impacted by gen...
Autores principales: | Li, Hongchuan, Anderson, Stephen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845690/ https://www.ncbi.nlm.nih.gov/pubmed/29559979 http://dx.doi.org/10.3389/fimmu.2018.00443 |
Ejemplares similares
-
TNFRSF13B Diversification Fueled by B Cell Responses to Environmental Challenges—A Hypothesis
por: Cascalho, Marilia, et al.
Publicado: (2021) -
Editorial: TNFRSF agonists: mode of action and therapeutic opportunities
por: Obermajer, Nataša, et al.
Publicado: (2023) -
Association of TNF-α, TNFRSF1A and TNFRSF1B Gene Polymorphisms with the Risk of Sporadic Breast Cancer in Northeast Chinese Han Women
por: Xu, Fengyan, et al.
Publicado: (2014) -
TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis
por: Zhang, Jun-rong, et al.
Publicado: (2021) -
TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA
por: Platt, Jeffrey L., et al.
Publicado: (2021)